These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 21376658)

  • 21. Characterization of newly established oral squamous cell carcinoma; 33-bp deletion in exons 3-4 of the p53 tumor suppressor gene.
    Hwang YS; Kim HJ; Kim J; Park KK; Chung WY
    Oral Oncol; 2012 Nov; 48(11):e39-41. PubMed ID: 22776128
    [No Abstract]   [Full Text] [Related]  

  • 22. Molecular findings in oral premalignant fields: update on their diagnostic and clinical implications.
    Gonzalez-Moles MA; Scully C; Ruiz-Avila I
    Oral Dis; 2012 Jan; 18(1):40-7. PubMed ID: 21851509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [p53 gene therapy for oral cancer].
    Liu SX; Hu M
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Sep; 47(9):569-72. PubMed ID: 23141735
    [No Abstract]   [Full Text] [Related]  

  • 24. Current trends in miRNAs and their relationship with oral squamous cell carcinoma.
    Pérez-Sayáns M; Pilar GD; Barros-Angueira F; Suárez-Peñaranda JM; Fernández AC; Gándara-Rey JM; García-García A
    J Oral Pathol Med; 2012 Jul; 41(6):433-43. PubMed ID: 22188431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequent promoter hypermethylation of RASSF1A and p16INK4a and infrequent allelic loss other than 9p21 in betel-associated oral carcinoma in a Vietnamese non-smoking/non-drinking female population.
    Tran TN; Liu Y; Takagi M; Yamaguchi A; Fujii H
    J Oral Pathol Med; 2005 Mar; 34(3):150-6. PubMed ID: 15689228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormalities of the human Rb tumor suppressor gene in oral squamous cell carcinoma.
    Huang H; Wang J; Li J
    Chin J Dent Res; 2000 Aug; 3(2):58-60. PubMed ID: 11314521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of heterozygosity of the APC gene in oral squamous cell carcinoma.
    Rivero ER; Horta MC; Silva Guerra EN; Ferraz AR; Nunes FD
    Pathol Res Pract; 2008; 204(11):793-7. PubMed ID: 18617334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated activity of cyclin-dependent kinase 6 in human squamous cell carcinoma lines.
    Timmermann S; Hinds PW; Münger K
    Cell Growth Differ; 1997 Apr; 8(4):361-70. PubMed ID: 9101082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional p53 status as a biomarker for chemotherapy response in oral-cavity cancer.
    Mroz EA; Rocco JW
    J Clin Oncol; 2010 Feb; 28(5):715-7. PubMed ID: 20048171
    [No Abstract]   [Full Text] [Related]  

  • 30. DNA methylation in oral squamous cell carcinoma: molecular mechanisms and clinical implications.
    González-Ramírez I; García-Cuellar C; Sánchez-Pérez Y; Granados-García M
    Oral Dis; 2011 Nov; 17(8):771-8. PubMed ID: 21781230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stressed marrow: FoxOs stem tumour growth.
    Coffer PJ; Burgering BM
    Nat Cell Biol; 2007 Mar; 9(3):251-3. PubMed ID: 17330117
    [No Abstract]   [Full Text] [Related]  

  • 32. Epigenetic inactivation of RASSF2 in oral squamous cell carcinoma.
    Imai T; Toyota M; Suzuki H; Akino K; Ogi K; Sogabe Y; Kashima L; Maruyama R; Nojima M; Mita H; Sasaki Y; Itoh F; Imai K; Shinomura Y; Hiratsuka H; Tokino T
    Cancer Sci; 2008 May; 99(5):958-66. PubMed ID: 18294275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular aspects of oral cancer.
    Nagler RM
    Anticancer Res; 2002; 22(5):2977-80. PubMed ID: 12530028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Skp2 is oncogenic and overexpressed in human cancers.
    Gstaiger M; Jordan R; Lim M; Catzavelos C; Mestan J; Slingerland J; Krek W
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5043-8. PubMed ID: 11309491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of adenomatous polyposis coli (APC) in tumorigenesis of human oral squamous cell carcinoma.
    Tsuchiya R; Yamamoto G; Nagoshi Y; Aida T; Irie T; Tachikawa T
    Oral Oncol; 2004 Oct; 40(9):932-40. PubMed ID: 15380172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of epidermal growth factor receptor signaling decreases p63 expression in head and neck squamous carcinoma cells.
    Matheny KE; Barbieri CE; Sniezek JC; Arteaga CL; Pietenpol JA
    Laryngoscope; 2003 Jun; 113(6):936-9. PubMed ID: 12782800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor suppressor genes and ROS: complex networks of interactions.
    Vurusaner B; Poli G; Basaga H
    Free Radic Biol Med; 2012 Jan; 52(1):7-18. PubMed ID: 22019631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral squamous cell carcinoma: overview of current understanding of aetiopathogenesis and clinical implications.
    Scully C; Bagan J
    Oral Dis; 2009 Sep; 15(6):388-99. PubMed ID: 19371401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Oral cancer and tumor suppressive gene p53].
    Hirano Y; Sakai H; Yamato T; Enomoto S; Tsuchida N
    Kokubyo Gakkai Zasshi; 1993 Mar; 60(1):216. PubMed ID: 8482907
    [No Abstract]   [Full Text] [Related]  

  • 40. Phospho-ΔNp63α-dependent microRNAs modulate chemoresistance of squamous cell carcinoma cells to cisplatin: at the crossroads of cell life and death.
    Ratovitski EA
    FEBS Lett; 2013 Aug; 587(16):2536-41. PubMed ID: 23831023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.